General Wellness & Medical Condition
In theory, the same therapy can be used to treat patients with Type 2 diabetes by replacing the failing b-cells. At this point, diabetes stem cell treatment alleviates the conditions and symptoms for patients, improving their overall quality of life, though it is not yet considered a complete cure to this disease.
Stem cells can migrate to the sites of injury attracted by specific chemicals released by the damaged tissue. The cell, by homing to the damaged area will fuse with the damaged tissue by the process of engraftment and become the same tissue by displaying the property of plasticity. Our COPD stem cell treatment program can greatly benefit patients with a range of lung diseases.
Currently, stem cell therapy is being used in orthopaedic conditions such as:
-Osteoarthritis: This is a degenerative joint ailment
-Chronic tendonitis: This is the inflammation of the elastic tissue that links bone to muscle
-Degenerative vertebral discs
-Bone fractures
-Chronic back pain
-Neck and shoulders pain
Stem cells facilitate this innate process by providing new cells in areas of deficiency. The growth factors, defender cells, coagulation cells, etc. are assisted by angiogenesis that provides new cells in the circulation to get the repaired area to work in concert and function properly.
Our liver disease stem cell treatment programs administer new pools of stem cells into the blood stream, with a carefully planned growth factor/peptide/stimulant program to support the stem cells mechanism we desire.
Mesenchymal cells have very strong plasticity, they can trans-differentiate into different kinds of tissue cells, plus they also trigger restoration of renal tissue injuries. The mesenchymal cells can trans-differentiate into renal cells and play an important role in the self restoration and regeneration of nephrons, post renal disease.
MSCs improve histological and functional outcomes in various CRF model systems. In addition, MSCs can reprogram kidney cells by fusion and differentiation, and modulate neo-kidney transplantation in CRF.
Adipose tissue has various cell types and one of them is the stromal-vascular fraction (SVF) which has a lot of adipose-derived stem cells as well as high concentrations of other crucial components like T-regulatory cells, endothelial precursor cells with strong immune-modulatory and anti-inflammatory features. Additionally, they easily integrate with different body specialized cells. They also create extra cells that assist other stem cells perform effectively as well as have the capacity to selective enhance injured tissues and repair them.
These stem cells release secretions of paracrine growth factors and cytokines such as VEGF, IL-8, and angiopoietin, which act by binding to a multitude of receptors that span the cell membrane in the ovaries.
High levels of these factors are secreted from the stem cells, facilitating the beneficial effects of these cells. Furthermore, these factors attach to receptors including the VEGF receptor VEGF-R2 and the Angiopoietin receptor Tie-2, both expressed upon a substantial percentage of progenitor cells, further enhancing tissue function and effectiveness.
MedCare autism stem cell therapy program works toward decreasing increase angiogenesis and blood flow to the brain, immune modulation and inflammation control in patients with autism alleviating autistic symptoms. The therapy has also been found to help in brain development for younger autistic children.
Autism stem cell therapy focuses on restoring lost or impaired neuron connections, forming new neuron connections and speeding up brain reactions by improving synaptic transmission and the development of new neuron connections.
Improvements experienced by autistic patients after stem cell therapy include increased; immunity, metabolism, communication ability, memory and learning capacity. Patients experience improvements in verbal skills, writing skills, self-care skills, attention span, concentration and tolerance to different foods.